Invited Commentary

Moving from Evidence to Impact for Human Papillomavirus Vaccination - The Critical Role of Translation and Communication in Epidemiology

Anne Rositch, Melinda Krakow

Research output: Contribution to journalReview article

Abstract

In response to the accompanying article by Yih et al. (Am J Epidemiol. 2018;187(6):1269-1276), we highlight the importance of moving beyond epidemiologic research on human papillomavirus (HPV) vaccine safety to focus on translation of this strong evidence base into successful vaccine safety communication strategies to bolster vaccine uptake. The potential of the HPV vaccine to reduce cancer incidence is substantial, yet actual HPV vaccination rates in the United States are disappointingly low in comparison with other routine childhood vaccines with similar safety profiles. This is no doubt due, in part, to persistent parental safety concerns. In 2016, safety remained the second most common reason for lack of vaccination intent by parents of unvaccinated adolescents. While the strong study by Yih et al. makes use of a novel statistical method and a large medical claims database to confirm the low occurrence of adverse events following HPV vaccination observed globally, their study also highlights a key challenge for epidemiologists: translating our research findings to other public health domains, so that evidence-informed communication strategies can be used to disseminate the information in a way that is understandable and useful to the public. Moving forward, multidisciplinary research teams will be essential to ensure that our epidemiologic findings have a broad public health impact.

Original languageEnglish (US)
Pages (from-to)1277-1280
Number of pages4
JournalAmerican Journal of Epidemiology
Volume187
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Vaccination
Epidemiology
Communication
Safety
Papillomavirus Vaccines
Vaccines
Public Health
Research
Public Sector
Parents
Databases
Incidence
Neoplasms

Keywords

  • adverse events
  • health communication
  • HPV vaccination
  • human papillomavirus
  • translational epidemiology
  • vaccine safety

ASJC Scopus subject areas

  • Epidemiology

Cite this

@article{94a206044c394d97bd8dc52c8fddf247,
title = "Invited Commentary: Moving from Evidence to Impact for Human Papillomavirus Vaccination - The Critical Role of Translation and Communication in Epidemiology",
abstract = "In response to the accompanying article by Yih et al. (Am J Epidemiol. 2018;187(6):1269-1276), we highlight the importance of moving beyond epidemiologic research on human papillomavirus (HPV) vaccine safety to focus on translation of this strong evidence base into successful vaccine safety communication strategies to bolster vaccine uptake. The potential of the HPV vaccine to reduce cancer incidence is substantial, yet actual HPV vaccination rates in the United States are disappointingly low in comparison with other routine childhood vaccines with similar safety profiles. This is no doubt due, in part, to persistent parental safety concerns. In 2016, safety remained the second most common reason for lack of vaccination intent by parents of unvaccinated adolescents. While the strong study by Yih et al. makes use of a novel statistical method and a large medical claims database to confirm the low occurrence of adverse events following HPV vaccination observed globally, their study also highlights a key challenge for epidemiologists: translating our research findings to other public health domains, so that evidence-informed communication strategies can be used to disseminate the information in a way that is understandable and useful to the public. Moving forward, multidisciplinary research teams will be essential to ensure that our epidemiologic findings have a broad public health impact.",
keywords = "adverse events, health communication, HPV vaccination, human papillomavirus, translational epidemiology, vaccine safety",
author = "Anne Rositch and Melinda Krakow",
year = "2018",
month = "6",
day = "1",
doi = "10.1093/aje/kwy024",
language = "English (US)",
volume = "187",
pages = "1277--1280",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Invited Commentary

T2 - Moving from Evidence to Impact for Human Papillomavirus Vaccination - The Critical Role of Translation and Communication in Epidemiology

AU - Rositch, Anne

AU - Krakow, Melinda

PY - 2018/6/1

Y1 - 2018/6/1

N2 - In response to the accompanying article by Yih et al. (Am J Epidemiol. 2018;187(6):1269-1276), we highlight the importance of moving beyond epidemiologic research on human papillomavirus (HPV) vaccine safety to focus on translation of this strong evidence base into successful vaccine safety communication strategies to bolster vaccine uptake. The potential of the HPV vaccine to reduce cancer incidence is substantial, yet actual HPV vaccination rates in the United States are disappointingly low in comparison with other routine childhood vaccines with similar safety profiles. This is no doubt due, in part, to persistent parental safety concerns. In 2016, safety remained the second most common reason for lack of vaccination intent by parents of unvaccinated adolescents. While the strong study by Yih et al. makes use of a novel statistical method and a large medical claims database to confirm the low occurrence of adverse events following HPV vaccination observed globally, their study also highlights a key challenge for epidemiologists: translating our research findings to other public health domains, so that evidence-informed communication strategies can be used to disseminate the information in a way that is understandable and useful to the public. Moving forward, multidisciplinary research teams will be essential to ensure that our epidemiologic findings have a broad public health impact.

AB - In response to the accompanying article by Yih et al. (Am J Epidemiol. 2018;187(6):1269-1276), we highlight the importance of moving beyond epidemiologic research on human papillomavirus (HPV) vaccine safety to focus on translation of this strong evidence base into successful vaccine safety communication strategies to bolster vaccine uptake. The potential of the HPV vaccine to reduce cancer incidence is substantial, yet actual HPV vaccination rates in the United States are disappointingly low in comparison with other routine childhood vaccines with similar safety profiles. This is no doubt due, in part, to persistent parental safety concerns. In 2016, safety remained the second most common reason for lack of vaccination intent by parents of unvaccinated adolescents. While the strong study by Yih et al. makes use of a novel statistical method and a large medical claims database to confirm the low occurrence of adverse events following HPV vaccination observed globally, their study also highlights a key challenge for epidemiologists: translating our research findings to other public health domains, so that evidence-informed communication strategies can be used to disseminate the information in a way that is understandable and useful to the public. Moving forward, multidisciplinary research teams will be essential to ensure that our epidemiologic findings have a broad public health impact.

KW - adverse events

KW - health communication

KW - HPV vaccination

KW - human papillomavirus

KW - translational epidemiology

KW - vaccine safety

UR - http://www.scopus.com/inward/record.url?scp=85049037502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049037502&partnerID=8YFLogxK

U2 - 10.1093/aje/kwy024

DO - 10.1093/aje/kwy024

M3 - Review article

VL - 187

SP - 1277

EP - 1280

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 6

ER -